Table 2 Absorbed organs dose per administered activity (± SD) for ⁶⁴CuCl₂

Adrenals

2.54E-2 (± 6.60E-3)

Brain

1.04E-2 (± 3.95E-3)

Breasts

1.22E-2 (± 4.07E-3)

Gallbladder wall

7.82E-2 (± 2.99E-2)

Lower larger intestine wall

1.25E-2 (± 4.76E-3)

Upper large intestine wall

1.78E-2 (± 5.31E-3)

Small intestine

1.62E-2 (± 5.42E-3)

Stomach wall

1.70E-2 (± 5.48E-3)

Heart wall

1.80E-2 (± 5.30E-3)

Kidneys

1.39E-1 (± 3.72E-2)

Liver

2.71E-1 (± 3.37E-2)

Lungs

1.64E-2 (± 4.88E-3)

Muscle

1.34E-2 (± 4.51E-3)

Pancreas

8.39E-2 (± 4.03E-2)

Red marrow

2.26E-2 (± 9.04E-3)

Osteogenic cells

3.00E-2 (± 1.16E-2)

Skin

1.09E-2 (± 3.84E-3)

Spleen

3.63E-2 (± 1.37E-2)

Testes

1.10E-2 (± 4.14E-3)

Thymus

1.31E-2 (± 4.53E-3)

Thyroid

1.16E-2 (± 4.31E-3)

Urinary bladder wall

1.27E-2 (± 4.69E-3)

Salivary glands

3.70E-2 (± 3.70E-2)

Total body

2.09E-2 (± 5.61E-3)

Effective dose ICRP 60 (mSv/MBq)

3.10E-2 (± 8.07E-3)

Effective dose ICRP 103 (mSv/MBq)

2.91E-2 (± 7.83E-3)